Results 261 to 270 of about 167,795 (308)

Combined modality therapy of malignant melanoma

World Journal of Surgery, 1979
AbstractThe major modalities of therapy, namely, surgery, radiotherapy, chemotherapy, and immunotherapy, are each of value in selected cases of malignant melanoma. However, because none of these therapies, alone, is capable of curing or controlling some subgroups of melanoma patients, combined modality therapy needs to be used more extensively. Surgery
E M, Hersh, J U, Gutterman, C M, McBride
openaire   +2 more sources

Combined modality therapy for esophageal cancer

Seminars in Oncology, 2003
Treatment approaches for esophageal cancer include primary treatment (surgical or nonsurgical) or adjuvant treatment (preoperative or postoperative). Primary treatments include surgery alone, radiation therapy alone, and radiation therapy plus chemotherapy (combined modality therapy).
openaire   +2 more sources

Combined modality therapy for intracranial tumors

Cancer, 1975
Three types of tumor (supratentorial astrocytoma, medulloblastoma, and craniopharyngioma), each requiring a fundamentally different therapeutic approach, will be used to illustrate the principles and practice of combined treatment in this field. The role of radiotherapy and ways of enhancing the effect of irradiation will be considered.
openaire   +2 more sources

Combination modality cancer therapy

International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1988
Coordination compounds for use in therapy, the compounds having the general empirical formula [Rhm Xx Yy ]a in which m is the oxidation state of Rh, X is at least one anionic ligand, Y is at least one neutral ligand, with the proviso that at least one of X and Y is a nitrogen donor ligand, x is an integer from 1 to 6, y is an integer from 1 to 5 or may
Donald H Picker, Paul C Hydes
openaire   +1 more source

Thyroid lymphoma. The case for combined modality therapy

Cancer, 1994
Radiation therapy with or without surgery is generally considered standard treatment for lymphoma of the thyroid. Because of the small number of cases, the role of chemotherapy or combined modality treatment is difficult to determine.The published literature was analyzed, supplemented by a series from Yale, for the incidence of local and distant ...
R, Doria, J F, Jekel, D L, Cooper
openaire   +2 more sources

Combined modality therapy of acute lymphocytic leukemia

Cancer, 1975
The progressive improvement in the prognosis of acute lymphocytic leukemia has been a result of two major developments: 1) the more efficient use of chemotherapeutic agents, particularly the use of combinations of agents and the discovery that agents effective at one stage of disease may be inappropriate at another stage, and 2) the prevention with ...
J V, Simone, R J, Aur, H O, Hustu, M, Verzosa, D, Pinkel   +4 more
openaire   +2 more sources

Preoperative combined modality therapy for pancreatic cancer

World Journal of Surgery, 1995
AbstractCombined modality therapy can be administered prior to surgical resection for patients with operable pancreatic cancer. One important criteria used to select patients for this treatment sequence is the absence of arterial vascular encasement by tumor on thin‐section CT scanning; the absence of peritoneal seeding on surgical staging or ...
T A, Rich, D B, Evans
openaire   +2 more sources

Taxanes in combined modality therapy for solid tumors

Critical Reviews in Oncology/Hematology, 2001
The taxanes, paclitaxel and docetaxel, are novel antimitotic agents that are under extensive investigation in clinical trials. Both taxanes have demonstrated significant activity against many solid tumors as single agents and in combination with other chemotherapeutic agents.
openaire   +3 more sources

Combined modality therapy in the treatment of gynecologic malignancies

Seminars in Oncology, 2003
During the last several years, combined modality therapy has become increasingly important in the treatment of several malignancies. This trend holds true in the treatment of the gynecologic malignancies. In this review we examine the evolving role of combined modality therapy in the treatment of patients with cervical, vulvar, endometrial, and ovarian
Mark A, Engleman, William, Small
openaire   +2 more sources

Chemotherapy and Combined-Modality Therapy for Esophageal Cancer

Chest, 1995
Treatment of esophageal carcinoma with radiation alone or surgery alone has yielded unsatisfactory cure rates and has not had a major impact on survival. The failure to cure or prolong survival of patients with esophageal cancer is because of our inability to eradicate residual disease at the primary site and to early systemic dissemination of disease.
D P, Kelsen, D H, Ilson
openaire   +2 more sources